Skip to main content

Table 1 Number of positive S. pneumoniae samples, proportion of total positive samples, odds ratio of carriage by serotype comparing children with ARI to healthy children in the community and odds ratio comparing serotypes causing IPD to carriage in healthy children in the community

From: Invasiveness potential of pneumococcal serotypes in children after introduction of PCV13 in Blantyre, Malawi

Serotype

Community samples

ARI samples

ARI/community samples

IPD samples

IPD/community samples

Spn positive (freq)

Proportion (%) [95% CI] (N = 3078)

Spn positive (freq)

Proportion (%) [95% CI] (N = 389)

OR (p value) [95% CI]

Age-adjusted OR (p value)

[95% CI]

Spn positive (freq)

Proportion (%) [95% CI] (N = 149)

OR (p value)

[95% CI]

Age-adjusted OR (p value)

[95% CI]

19F

146

4.7 [4.0–5.6]

29

7.5 [5.0–10.5]

1.62 (0.023)

[1.05–2.41]

1.81 (0.007)

[1.16–2.75]

1

0.7 [0.0–3.7]

0.14 (0.047)

[0.01–0.61]

0.15 (0.061)

[0.01–0.69]

3

122

3.9 [3.3–4.7]

9

2.3 [1.1–4.3]

0.57 (0.112)

0.67 (0.266)

[0.31–1.28]

4

2.7 [0.7–6.7]

0.67 (0.434)

[0.20–1.62]

0.82 (0.699)

[0.24–2.01]

23F

120

3.9 [3.2–4.6]

18

4.6 [2.8–7.2]

[0.27–1.08]

1.20 (0.489)

[0.70–1.93]

1.29 (0.347)

[0.74–2.12]

11

7.4 [3.7–12.8]

1.96 (0.039)

[0.98–3.57]

2.06 (0.032)

[1.01–3.84]

14

91

3.0 [2.4–3.6]

8

2.0 [0.9–4.0]

0.69 (0.318)

[0.31–1.34]

0.66 (0.270)

[0.29–1.30]

5

3.4 [1.1–7.7]

1.14 (0.780)

[0.40–2.58]

1.06 (0.909)

[0.36–2.45]

6A

89

2.9 [2.3–3.5]

3

0.8 [0.2–2.2]

0.26 (0.023)

[0.06–0.70]

0.26 (0.023)

[0.06–0.70

5

3.4 [1.1–7.7]

1.17 (0.742)

[0.41–2.64]

1.19 (0.717)

[0.41–2.76]

19A

44

1.4 [1.0–1.9]

10

2.5 [1.2–4.7]

1.82 (0.091)

[0.86–3.50]

2.01 (0.061)

[0.92–4.01]

0

0

0 (0.979)

0 (0.979)

9V

29

0.9 [0.6–1.3]

2

0.5 [0.1–1.8]

0.54 (0.405)

[0.09–1.81]

0.57 (0.444)

[0.09–1.95]

2

1.3 [0.2–4.8]

1.43 (0.627)

[0.23–4.81]

1.67 (0.498)

[0.26–5.91]

6B

27

0.9 [0.6–1.3]

4

1.0 [0.3–2.6]

1.17 (0.766)

[0.35–3.02]

1.08 (0.888)

[0.31–2.86]

6

4.0 [1.5–8.6]

4.74 (< 0.001)*

[1.75–10.93]

4.73 (0.001)*

[1.66–11.64]

18C

16

0.5 [0.3–0.8]

0

0

0 (0.986)

0 (0.986)

3

2.0 [0.4–5.8]

3.93 (0.031)

[0.91–11.97]

3.67 (0.053)

[0.80–12.18]

1

13

0.4 [0.2–0.7]

1

0.3 [0.0–1.4]

0.61 (0.632)

[0.03–3.06]

0.81 (0.840)

[0.04–4.45]

13

8.7 [4.7–14.4]

22.54 (< 0.001)*

[10.16–50.0]

23.38 (< 0.001)*

[9.75–56.06]

4

12

0.4 [0.2–0.6]

1

0.3 [0.0–1.4]

0.66 (0.688)

[0.04–3.35]

0.81 (0.846)

[0.04–4.52]

1

0.7 [0.0–3.7]

1.73 (0.601)

[0.09–8.85]

2.76 (0.341)

[0.15–15.08]

5

7

0.2 [0.1–0.5]

3

0.8 [0.2–2.2]

3.41 (0.076)

[0.73–12.32]

6.09 (0.018)

[1.18–25.24]

8

5.4 [2.3–10.3]

24.89 (< 0.001)*

[8.82–71.92]

24.73 (< 0.001)*

[7.90–78.56]

7F

3

0.1 [0.0–0.3]

2

0.5 [0.1–1.8]

5.30 (0.068)

[0.70–32.06]

5.53 (0.082)

[0.67–39.03]

1

0.7 [0.0–3.7]

6.93 (0.095)

[0.34–54.46]

6.60 (0.132)

[0.29–62.57]

Total VT

719

23.4 [21.9–24.9]

90

23.1 [19.0–27.7]

60

40.3 [32.3–48.6]

Total NVT

2359

76.6 [75.1–78.1]

299

76.9 [72.3–81.0]

89

59.7 [51.4–67.7]

Total

3078

 

389

   

 149

   
  1. Spn: Streptococcus pneumoniae; VT: vaccine serotype; NVT: non-vaccine serotype; IPD: invasive pneumococcal disease; ARI: acute respiratory infection; freq: frequency; CI: confidence interval; OR: odds ratio; age-adjusted OR: odds ratio with age included in logistic regression model
  2. *P value < 0.002 considered statistically significant based on Bonferroni correction